Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ottestad

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
British Journal of Cancer|October 1, 1990
Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosisA L Børresen, L Ottestad, A Gaustad, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATMK Laake, A Odegård, T I Andersen, et al.
Cancer Research|June 1, 1992
Screening for germ line TP53 mutations in breast cancer patientsA L Børresen, T I Andersen, J Garber, et al.
The Journal of Pathology. Clinical Research|January 27, 2021
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapySissel Gyrid Freim Wahl, Hong Yan Dai, Elisabeth F Emdal, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapyS I Helle, W Mietlowski, J P Guastalla, et al.
Scientific Reports|February 5, 2021
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNAThomas L Dunwell, Simon C Dailey, Anine L Ottestad, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
British Journal of Cancer|October 1, 1990
Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosisA L Børresen, L Ottestad, A Gaustad, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATMK Laake, A Odegård, T I Andersen, et al.
Cancer Research|June 1, 1992
Screening for germ line TP53 mutations in breast cancer patientsA L Børresen, T I Andersen, J Garber, et al.
The Journal of Pathology. Clinical Research|January 27, 2021
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapySissel Gyrid Freim Wahl, Hong Yan Dai, Elisabeth F Emdal, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapyS I Helle, W Mietlowski, J P Guastalla, et al.
Scientific Reports|February 5, 2021
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNAThomas L Dunwell, Simon C Dailey, Anine L Ottestad, et al.
Pageof 3